Hodgkin's disease: subsequent primary cancers in relation to treatment
1988

Hodgkin's Disease and Subsequent Cancers

Sample size: 2999 publication Evidence: moderate

Author Information

Author(s): P. Prior, D.J. Pope

Primary Institution: Cancer Epidemiology Research Unit, Department of Social Medicine, University of Birmingham

Hypothesis

What is the relationship between treatment for Hodgkin's disease and the risk of subsequent primary cancers?

Conclusion

Patients treated for Hodgkin's disease have a significantly increased risk of developing subsequent primary cancers, particularly acute leukaemias and solid tumours.

Supporting Evidence

  • Patients treated with chemotherapy had a significantly increased risk of acute leukaemias.
  • Solid tumours showed increased risks, particularly in the lung, breast, and bone.
  • The overall risk of subsequent cancers was found to be 50% higher than the general population.
  • Among patients treated after 1968, the risk of acute leukaemias was significantly elevated.

Takeaway

If you get treated for Hodgkin's disease, you might have a higher chance of getting other types of cancer later on.

Methodology

The study analyzed a cohort of 2,999 Hodgkin's disease patients from cancer registry records, focusing on subsequent primary cancers after treatment.

Potential Biases

Potential biases due to varying treatment modalities and patient demographics.

Limitations

The follow-up period may not be long enough to determine long-term effects of treatment on cancer incidence.

Participant Demographics

The cohort included 1,826 men and 1,173 women diagnosed with Hodgkin's disease between 1950 and 1979.

Statistical Information

P-Value

p<0.01

Confidence Interval

95% CI 6.4-46.7

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication